Protein domains in the hepatic glycogen-targetting subunit of protein phosphatase 1 and methods of making and using the same
CA 2340885 A1 · Owner: Armstrong, Christopher George · Inventors: Armstrong, Christopher George; Doherty, Martin John; Cohen, Patricia Townsend Wade
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to compounds useful for treating disorders associated with abnormal blood glucose levels in mammals such as Type I and , Type II diabetes. The invention also relates to methods of making and using such compounds.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 19, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 19, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 19, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.